September update: Revolutions in neurotechnology will soon influence every aspect of human life

Time for Sharp­Brains’ Sep­tem­ber e‑newsletter, wrap­ping up this month’s key brain-relat­ed news. Our brain is at the core of every­thing we do, from the every-day deci­sions we make to the epic emo­tions we feel when we fall in love. And neurotechnologies–especially those that, being dig­i­tal, are emi­nently scal­able, and that, being non-inva­­sive, pose few if any negative…

Read More

Neosync ranked #30 Holder of Pervasive Neurotech Intellectual Property*

Neo­sync is an ear­ly stage com­pa­ny devel­op­ing a new treat­ment  for major depres­sion based on Tran­scra­nial Mag­net­ic Stim­u­la­tion (TMS). The treatment–named NEST (Neo­sync EEG Syn­chro­nized TMS) and under­go­ing clin­i­cal trials–is based on the idea that depres­sion patients tend to have over­ly rhyth­mic brain activity, 

Read More